Immunic Historical Financial Ratios

IMUX -  USA Stock  

USD 8.61  0.25  2.99%

Immunic is lately reporting on over 58 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Debt to Equity Ratio of 0.0615 or Price to Book Value of 2.32 will help investors to properly organize and evaluate Immunic financial condition quickly. Financial Statement Analysis is infinitely more than just reviewing and investigating Immunic recent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunic is a good buy for the upcoming year.
Please see Risk vs Return Analysis.

Immunic Historical Statements 

 
Refresh

About Immunic Financial Ratios Analysis

ImmunicFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Immunic investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Immunic financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Immunic history.

Immunic Financial Ratios Chart

Immunic financial ratios usually calculated using numerical values taken directly from Immunic financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Immunic. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
Immunic Book Value per Share is fairly stable at the moment as compared to the past year. Immunic reported Book Value per Share of 10.14 in 2020. Debt to Equity Ratio is likely to rise to 0.06 in 2021, whereas Current Ratio is likely to drop 13.80 in 2021.

Current Ratio

The ratio between Current Assets and Current Liabilities; for companies that operate a classified balance sheet.

Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].
Most ratios from Immunic fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Immunic Book Value per Share is fairly stable at the moment as compared to the past year. Immunic reported Book Value per Share of 10.14 in 2020. Debt to Equity Ratio is likely to rise to 0.06 in 2021, whereas Current Ratio is likely to drop 13.80 in 2021.

Immunic fundamentals Correlations

Immunic Account Relationship Matchups

Immunic fundamentals Accounts

201620172018201920202021 (projected)
Book Value per Share74.4850.22(30.39)7.5610.1410.94
Current Ratio11.225.656.944.5615.9313.8
Debt to Equity Ratio0.0950.21(0.075)0.130.0570.0615
Enterprise Value over EBITDA(1.82)(3.62)0.86(1.94)(4.19)(4.52)
Free Cash Flow per Share(46.3)(41.22)(11.53)(3.7)(2.95)(3.19)
Price to Book Value2.385.02(0.31)1.682.02.32
Price to Earnings Ratio(3.32)(4.54)(0.55)(2.15)(5.44)(5.87)
Return on Average Assets(0.55)(0.69)(0.4)(0.64)(0.36)(0.39)
Return on Average Equity(0.71)(0.59)(0.77)(0.88)(0.39)(0.42)
Return on Invested Capital110.9513.042.8823.3650.1542.88
Tangible Assets Book Value per Share81.5960.615.794.278.618.84

Immunic Investors Sentiment

The influence of Immunic's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunic. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - IMUX

Immunic Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunic. What is your judgment towards investing in Immunic? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunic using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunic information on this page should be used as a complementary analysis to other Immunic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Immunic Stock analysis

When running Immunic price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.